CPH:ONXEO

Onxeo Stock

DENMARK |CO |DKK

Price
kr4.15
Change
-2.12%
Today's Range
kr4.14 - kr4.28
52-Week Range
kr4.05 - kr6.12
Market Cap
kr387.14M
Volume
38.49K

About Onxeo (CPH:ONXEO)

(CPH:ONXEO) Onxeo SA, a clinical-stage biotechnology company, designs and develops oncology drugs for tumor DNA repair functions worldwide. The company offers Beleodaq for the treatment of relapsed or refractory peripheral T-cell lymphoma. It also develops AsiDNA, which is in Phase 1 clinical trial for the treatment of metastatic melanoma; OX401, which is in preclinical stage for treating DNA damage response and immuno-oncology; and Validive, which completed Phase II clinical trial for the treatment of oral mucositis in patients treated for a head and neck cancer. Onxeo SA has a collaboration and licensing agreement with Spectrum Pharmaceuticals for the development of Beleodaq; a license agreement with Monopar Therapeutics Inc. to develop Validive; and clinical research agreement with Gustave Roussy to conduct clinical trial of AsiDNA for the treatment of relapsed ovarian cancer. The company was formerly known as BioAlliance Pharma SA and changed its name to Onxeo SA in July 2014. Onxeo SA was founded in 1997 and is headquartered in Paris, France.
Show more

ONXEO Stock Price

Statistics Highlights (CPH:ONXEO)

Shares Outstanding 91.70M Beta 1.49
Public Float 62.62M P/E Ratio -
% Short of Float - Dividend (Yield) -
Held by Insiders 16.52% Ex-Dividend Date
Held by Institutions 9.67% IPO Date -

ONXEO Financial Summary

|
Dec 20 Dec 19 Dec 18
Revenue kr1.78M kr4.29M kr6.13M
EBITDA kr3.42M kr-9.62M kr-947.00K
Net Income kr1.09M kr-33.73M kr-9.40M
Total Assets kr46.51M kr37.63M kr63.25M
Total Cash kr14.52M kr5.71M kr11.25M
Total Debt kr kr kr
Jun 21 Mar 21 Dec 20
Revenue kr kr kr
EBITDA kr kr kr
Net Income kr kr kr
Total Assets kr56.07M kr kr46.51M
Total Cash kr24.46M kr kr14.52M
Total Debt kr kr kr

ONXEO Stock Price History

Onxeo Annual Stock Price History

Year Open Close Change
2021 kr4.93 kr4.15 -15.82%
2020 kr3.85 kr4.93 28.22%

Onxeo Daily Stock Price History

Date Open High Low Close Change Volume
Sep 16, 2021 kr4.24 kr4.28 kr4.14 kr4.15 -2.12% 38.49K
Sep 15, 2021 kr4.40 kr4.43 kr4.22 kr4.24 0.12% 52.20K
Sep 14, 2021 kr4.39 kr4.40 kr4.24 kr4.24 -1.51% 31.26K

(CPH:ONXEO) Stock Price FAQs

What is today's stock price of Onxeo (CPH:ONXEO)?

  • The current stock price of Onxeo (CPH:ONXEO) is kr4.15.
  • Today ONXEO stock price opened at kr4.24 after previous close of kr4.24.
  • During the day, Onxeo stock quote has varied from a low of kr4.14 to a high of kr4.28.

What is Onxeo's 52-week change?

  • ONXEO 52-week high stock quote is kr6.12, which is 47.50% above the current share price.
  • The Onxeo (CPH:ONXEO) 52-week low stock price is kr4.06, which is 2.30% below the current share price.
  • Onxeo share price volatility (52-week beta) is 1.49.

Onxeo (CPH:ONXEO) FAQ

How Much is Onxeo Worth?

Onxeo's worth today based on market capitalisation is kr387.14M

How much dividend does Onxeo Pay?

The current annualized dividend payout for ONXEO stock is kr0.00, the dividend yield is 0.00% and the payout ratio is 0.00%.
View More Details on Onxeo's "Dividend" Section

What is Onxeo’s Price to Earning (PE) ratio?

ONXEO stock also has a Price to Sales (P/S) ratio of 37.38, a Price to Book of 1.55 and Price/Earnings to Growth (PEG) of 0.00.

What is the Onxeo's ticker?

Onxeo trades on the Copenhagen stock market in Denmark under the ticker symbol "ONXEO". Onxeo’s stock symbol can also be displayed as "CPH:ONXEO".

Who are the owners of Onxeo?

Onxeo (CPH:ONXEO) is owned by 9.66% institutional shareholders and by 16.52% insiders. The rest is owned by the public.
Explore More Details on Onxeo's “Ownership” Section

Who are the key executives of Onxeo (ONXEO)?

Onxeo's key executive team includes the following managers:

  • Ms. Judith Greciet Ph.D., Pharmacy, CEO & Director (1968)
  • Mr. Nicolas Fellmann, CFO & Admin. and Fin. Director (1968)
  • Dr. Françoise Bono Ph.D., Chief Scientific Officer (NA)
  • Ms. Audrey Legentil-Dumery, Director of HR (NA)
  • Mr. Michel Forest, Chief Pharmacist & Quality Assurance Director (NA)
  • Mr. Philippe M. Maitre, Chief of US Operations & Exec. VP (1957)
  • Dr. Olivier de Beaumont M.D., MBA, Chief Medical Officer (NA)

What is Onxeo’s Sector & Industry Classification?

Onxeo (CPH:ONXEO) is classified under the "Healthcare" sector and under the "Biotechnology" industry.

How many employees work for Onxeo?

Currently the number of employees working for Onxeo is 29.

Where are Onxeo's Headquarters?

Onxeo (CPH:ONXEO) is headquartered in France.

What are Onxeo's Address and Phone Number?

Onxeo’s mailing address is 49, boulevard du GEnEral Martial Valin, Paris, France, 75015.
The company’s phone number is 33 1 45 58 76 00.

What is the official website for Onxeo?

Onxeo’s official website is http://www.onxeo.com